Patients with pulmonary arterial hypertension (PAH) can develop several complications with the progression of the disease or as a result of hemodynamic imbalance. Some of these complications include ...

The primary drivers of biologic switching in GPP include lack of efficacy, loss of response over time, adverse effects, and safety concerns. Switching biologic therapies for generalized pustular ...

(Getty Images) Dietitians and nutrition played a key role in managing IgAN, participants in a virtual focus group reported. BOSTON—A focus group of patients with immunoglobulin A nephropathy (IgAN) ...

Fire ants are the leading cause of anaphylaxis triggered by Hymenoptera insect stings in the United States. Fire ant (FA) venom-associated anaphylaxis is a significant and growing healthcare burden in ...

Over half of the flares led to hospitalization, with 61 out of 97 patients hospitalized for 1 to less than 5 weeks for their most severe flare. Patients with generalized pustular psoriasis (GPP) ...

Although there are no current treatment guidelines for GPP in pregnancy, the goal of therapy is to improve prognosis and enhance quality of life, while ensuring the health of both patient and fetus.

(Getty Images) The patient, who had rapid progressive glomerulonephritis and ANCA-positive IgAN, responded well to immunosuppressants. The case study highlights the potential role of IgA in the ...

To develop the combined model, the researchers integrated the imaging-derived radiomics score from the best-performing radiomics model (random forest) with the clinical model. A new combination ...

Because mast cell disorders comprise a range of clonal and nonclonal mast cell conditions and might share some similar clinical symptoms, a comprehensive diagnostic approach is needed to establish an ...

Well, spring has finally sprung, and I am thankful for that. I have cold agglutinin disease (CAD), which means that cold air is my enemy. It always sounds funny to say that, but it is true. Cold air ...

The study aims to find the best therapeutic dose for improved SM disease control without excessive toxicity. A study is recruiting patients with systemic mastocytosis (SM) with an associated ...

Kate Stringaris, a researcher with the National Heart, Lung, and Blood Institute—a division of the National Institutes of Health in Bethesda, Maryland—separates lymphocytes from a blood sample as part ...